Camtek director reports initial share and RSU holdings

Camtek Ltd director Aviram Lior filed an initial ownership report showing direct holdings of ordinary shares and multiple equity awards.

Rhea-AI Filing Summary

Camtek Ltd director Aviram Lior filed an initial ownership report showing direct holdings of ordinary shares and multiple equity awards. The filing lists positions in ordinary shares, including one line with 13,387 ordinary shares held directly, alongside smaller direct holdings reported separately.

The footnotes explain that Lior has been granted restricted stock units (RSUs), each representing a contingent right to receive one ordinary share of Camtek. One RSU grant vests 25% on June 1, 2026, with the remaining 75% vesting in twelve equal quarterly installments thereafter, conditioned on continued service. Another RSU grant vests in full on June 1, 2026, and a further grant vests 25% on March 30, 2027 with the balance vesting in twelve equal quarterly installments, also subject to ongoing service.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Aviram Lior

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 19,211 shares (Direct)

Footnotes (3)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company"). The RSUs vest 25% on the first vesting date (06/01/2026) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
2. F2. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest on 06/01/2026, subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.
3. F3. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest 25% on the first Vesting Date (03/30/2027) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

Key Figures

Direct ordinary share holding: 13,387 ordinary shares Additional direct holding: 3,347 ordinary shares Additional direct holding: 2,477 ordinary shares +4 more

7 metrics

Direct ordinary share holding 13,387 ordinary shares Directly held position reported in Form 3

Additional direct holding 3,347 ordinary shares Separate direct ordinary share line in Form 3

Additional direct holding 2,477 ordinary shares Another direct ordinary share line in Form 3

RSU vesting initial tranche 25% of grant Vests on June 1, 2026, remainder quarterly thereafter

Remaining RSU vesting 75% of grant Vests in 12 equal quarterly installments after June 1, 2026

Single-tranche RSU vesting 100% of grant Vests on June 1, 2026 subject to continued service

Later RSU initial vesting 25% of grant Vests on March 30, 2027, rest quarterly thereafter

Key Terms

restricted stock units ("RSUs"), contingent right to receive one ordinary share, vesting date, twelve equal quarterly installments, +1 more

5 terms

restricted stock units ("RSUs") financial

"The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right to receive one ordinary share financial

"which each represent a contingent right to receive one ordinary share of Camtek Ltd."

vesting date financial

"The RSUs vest 25% on the first vesting date (06/01/2026)..."

twelve equal quarterly installments financial

"the remaining 75% vest in twelve equal quarterly installments thereafter..."

continued service financial

"subject to the Reporting Person's continued service to the Company or its subsidiaries..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Aviram Lior for CAMT show?

The Form 3 filing shows that director Aviram Lior reports direct ownership of ordinary shares in Camtek Ltd (CAMT) and several RSU grants. It establishes his initial beneficial ownership position, including current shares and future share rights subject to vesting.

How many Camtek (CAMT) ordinary shares does Aviram Lior report directly holding?

The filing lists several direct ordinary share positions, including one line with 13,387 ordinary shares. Additional smaller direct holdings are reported separately. These figures reflect his beneficial ownership of Camtek’s ordinary shares as of the Form 3 reporting date.

What are the key RSU vesting terms disclosed for Aviram Lior at Camtek (CAMT)?

One RSU grant vests 25% on June 1, 2026 and the remaining 75% in twelve equal quarterly installments. Another grant vests fully on June 1, 2026, while a further grant vests 25% on March 30, 2027 with the balance vesting quarterly thereafter.

Do the RSUs in the Camtek (CAMT) Form 3 immediately give Aviram Lior ordinary shares?

No. The RSUs each represent a contingent right to receive one ordinary share of Camtek. Shares are delivered only as the RSUs vest on specified dates and only if Aviram Lior continues serving the company or its subsidiaries through each vesting date.

What conditions affect RSU vesting for Aviram Lior at Camtek (CAMT)?

All RSU vesting is expressly conditioned on continued service to Camtek Ltd or its subsidiaries through the applicable vesting dates. If service does not continue, unvested RSUs may be forfeited under the award terms described in the Form 3 footnotes.

Does Aviram Lior’s Camtek (CAMT) Form 3 indicate any recent share purchases or sales?

The Form 3 functions as an initial ownership report and lists holdings and RSU grants. The transaction records are coded as holdings with an unknown transaction code, so the filing does not explicitly show recent open-market purchases or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/13/2026 - 08:33 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Aviram Lior

(Last) (First) (Middle)

HOFAIN

(Street)

TEL AVIV 00000

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2026

3. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	13,387(1)	D
Ordinary Shares	3,347(2)	D
Ordinary Shares	2,477(3)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company"). The RSUs vest 25% on the first vesting date (06/01/2026) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

2. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest on 06/01/2026, subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.

3. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest 25% on the first Vesting Date (03/30/2027) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

Remarks:

This Form 3 has been filed after March 18, 2026 but prior to April 20, 2026 in reliance on the temporary relief made available to the directors and officers of certain foreign private issuers by the Staff of the Securities and Exchange Commission in its no-action letter dated March 13, 2026.

	Lior Aviram by: Oppenheimer Israel, as Attorney-in-fact	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)